Smith Thomas B (CIK 1748462) reported 9 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-02-12). Recent activity: Buy COLL (22,774 shares), Sell COLL (5,897 shares), Sell COLL (11,538 shares), Buy COLL (14,268 shares), Sell COLL (17,478 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-12 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | EVP and Chief Medical Officer | Buy | 22,774 | $0 |
| 2026-02-12 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | EVP and Chief Medical Officer | Sell | 5,897 | $275,685 |
| 2026-02-12 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | EVP and Chief Medical Officer | Sell | 11,538 | $539,402 |
| 2026-02-12 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | EVP and Chief Medical Officer | Buy | 14,268 | $0 |
| 2025-09-03 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | EVP and Chief Medical Officer | Sell | 17,478 | $671,505 |
| 2025-02-12 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | EVP and Chief Medical Officer | Sell | 4,399 | $134,257 |
| 2025-02-12 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | EVP and Chief Medical Officer | Buy | 33,762 | $0 |
| 2025-02-12 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | EVP and Chief Medical Officer | Buy | 5,313 | $0 |
| 2025-02-12 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | EVP and Chief Medical Officer | Sell | 1,498 | $45,719 |
Source: SEC Form 4 filings · as of 2026-02-12